Systemic Therapy of Atopic Dermatitis: Welcome to the Revolution.
Semin Cutan Med Surg
; 36(4S): S103-S105, 2017 12 01.
Article
em En
| MEDLINE
| ID: mdl-29659645
ABSTRACT
Until recently, systemic therapy of atopic dermatitis was limited to off-label use of immunomodulators, which can pose significant safety concerns, and treatment with systemic corticosteroids, not recommended in the most recent guidelines. The introduction of dupilumab in 2017 marked a major advance in systemic therapy for atopic dermatitis. It has demonstrated long-term efficacy in adults with moderate to severe disease, and is being studied in children. Several other biologic agents and "small molecules" with varying mechanisms of action are in phase 2 or 3 development. Semin Cutan Med Surg 36(supp4)S103-S105.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article